This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (2230) Diabetes (93) Diabetes Self-Management (383) Hypertension Prevention and Treatment (167)

Published on in Vol 21 , No 10 (2019) :October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15814, first published .
Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Authors of this article:

Robert J Nordyke 1 Author Orcid Image ;   Kevin Appelbaum 2 Author Orcid Image ;   Mark A Berman 2 Author Orcid Image
Article Authors Cited by (21) Tweetations (30) Metrics

Robert J Nordyke   1 * , BSc, MSc, PhD ;   Kevin Appelbaum   2 * , BSE ;   Mark A Berman   2 * , BSc, MD

1 Beta6 Consulting Group, LLC, Topanga, CA, US

2 Better Therapeutics, LLC, San Francisco, CA, US

*all authors contributed equally

Corresponding Author: